Crossmark

Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1

Crossref DOI link: https://doi.org/10.15252/embr.202255839

Published Online: 2022-10-21

Published Print: 2022-12-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peng, Ruoshi https://orcid.org/0000-0001-5488-4399
Wang, Chris Kedong

Wang‐Kan, Xuan

Idorn, Manja

Kjær, Majken https://orcid.org/0000-0002-3511-2550
Zhou, Felix Y https://orcid.org/0000-0003-4463-1165
Fiil, Berthe Katrine

Timmermann, Frederik

Orozco, Susana L https://orcid.org/0000-0003-1741-6275
McCarthy, Julia

Leung, Carol S

Lu, Xin https://orcid.org/0000-0002-6587-1152
Bagola, Katrin https://orcid.org/0000-0003-0269-6454
Rehwinkel, Jan https://orcid.org/0000-0003-3841-835X
Oberst, Andrew

Maelfait, Jonathan https://orcid.org/0000-0002-1476-0583
Paludan, Søren R https://orcid.org/0000-0001-9180-4060
Gyrd‐Hansen, Mads https://orcid.org/0000-0001-5641-5019
Funding

Funding for this research was provided by:

China Scholarship Council‐University of Oxford DPhil Scholarship (GAF1516_CSCUO_841725)

EC¦European Research Council (ERC‐AdG ENVISION; 786602)

LEO Fondet

Ludwig Institute for Cancer Research

Novo Nordisk Fonden (NNF20OC0059392)

Novo Nordisk Fonden (NNF18OC0030274)

The independent research fund Denmark (0214‐00001B)

Wellcome Trust (102894/Z/13/Z)

Wellcome Trust (215612/Z/19/Z)
License Information

Text and Data Mining valid from 2022-10-21

Version of Record valid from 2022-10-21
More Information

Article History

Received: 22 July 2022

Revised: 6 October 2022

Accepted: 7 October 2022

First Online: 21 October 2022

Disclosure and competing interests statement

: All authors declare they have no conflict of interest relating to this study.

Document is current

Any future updates will be listed below